EnviroStar, Inc. EVI 深 滬
等待開盤 10-23 09:30:00 美东时间
26.57
+0.540
+2.07%
華盛通- 最 高26.57
- 今 開26.03
- 成交量 8825股
- 最 低 25.99
- 昨 收 26.03
- 總市值 3.39亿
- 52周最高 34.49
- 市盈率 靜 54.41
- 換手率 0.07%
- 52周最低 14.663
- 委 比 0.00%
- 總股本 1276.20万
- 歷史最高 47.40
- 量 比 0.53
- 振 幅 2.23%
- 歷史最低 -0.69
- 每 手 1
- 風險率 4.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Reported Earlier: Imunon To Give Oral Presentations Highlighting IMNN-101, Its Investigational DNA Plasmid Vaccine Based On The Company's Proprietary PlaCCine Technology Platform At Leading Vaccine Conferences
LAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapies and evaluating an adaptation of the platform's
10-17 23:41
更大更省！盾安大涡旋“双子星”重磅布局，领跑绿色冷暖新赛道
（来源：盾安环境） 在倡导绿色发展的今天，高效节能的中央空调产品正成为建筑减排的关键。盾安中央空调始终致力于技术创新，紧跟国家“双碳”战略，推出两款旗舰级...
10-13 16:32
Royce Micro-Cap Trust (NYSE: RMT) as of Aug 31, 2025
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Average weekly trading volume of app...
09-26 01:31
老黄刚投的具身智能公司：三个华人创办
Jay 发自 凹非寺 量子位 | 公众号 QbitAI 老黄又投了一家具身智能公司！ Dyna Robotics，1年前刚成立，现在对外官宣了1.2亿美元（折合...
09-21 10:11
IMUNON To Present New Translational Data From Phase 2 OVATION 2 Study Of IMNN-001 At 2025 AACR Special Conference In Cancer Research
OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treatedLAWRENCEVILLE, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3
09-19 20:07
CARFAX: Fall Is Most Dangerous Season For Car Accidents in the U.S.
The Season with the Most Accidents is Fall for 39 of 50 U.S. States CENTREVILLE, Va., Sept. 17, 2025 /PRNewswire/ -- Next week, tens of millions of drivers will hit the roads during what CAR...
09-17 21:00
美股大行评级 | Arete Research上调百度"买入"评级，目标价143美元；瑞银上调蔚来"买入"评级，目标价升至8.5美元
今日重点评级关注：HC Wainwright & Co.：维持Orion Energy Sys"买入"评级，目标价从2美元升至20美元；高盛：维持Amylyx Pharmaceuticals"买入"评级，目标价从10美元升至20美元
09-17 10:15
Sidoti Events, LLC's Virtual September Small-Cap Conference
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an af...
09-16 23:20
美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
09-15 11:13
DA Davidson Maintains Buy on EVI Industries, Maintains $28 Price Target
DA Davidson analyst Michael Shlisky maintains EVI Industries (AMEX:EVI) with a Buy and maintains $28 price target.
09-12 23:03
